Cancer Epidemiology, screening, Diagnosis & Prognosis

The Epidemiology of Cancer is the study of the factors affecting Cancer, a way to conclude possible tendencies and causes. The study of Cancer Epidemiology practices Epidemiological Methods to discover the cause of Cancer and to recognize and develop enhanced treatments. This extent of study must cope with difficulties of lead time bias and length time bias. Lead time bias is the theory that primary diagnosis may artificially inflate the survival statistics of a Cancer, without actually improving the natural history of the disease. Length bias is the concept that tender growing, more lethargic Tumors are more likely to be recognised by Screening Tests, but improvements in diagnosing more cases of indolent Cancer may not translate into better patient outcomes after the implementation of Screening Programs.

Most Cancers are originally known either because of the appearance of signs or symptoms or through Screening. Neither of these leads to a Definitive Diagnosis, which comprises the examination of a tissue sample by a pathologist. People with suspected Cancer are observed with medical tests. These generally include Blood Tests, CT Scans, X-rays and Endoscopy.

Screenings can find initial Cancer, when it’s most curable. Cancer Screening aims to identify Cancer before symptoms appear. This may include blood tests, urine tests, other tests, or Medical Imaging. The aids of screening in terms of Cancer Prevention, early detection and subsequent treatment must be weighed beside any harm. Worldwide screening, Population Screening or Mass Screening involves screening everyone, generally within a definite age group. Selective Screening detects people who are known to be at advanced risk of developing Cancer, such as people with a family history of Cancer.

  • Circulating tumor cells (CTCs) towards cancer Diagnosis
  • Microfluidic device for cancer screening
  • Cancer Staging
  • Early detection and diagnosis of Cancer
  • Early detection and diagnosis of Cancer

Related Conference of Cancer Epidemiology, screening, Diagnosis & Prognosis

October 23-24, 2019

15th World Congress on Blood Cancer

Prague, Czech Republic

PANAROMA HOTEL PRAGUE - Milevská 7, 140 63 Praha 4-Nusle, Czechia
October 23-24, 2019 |

Women Oncology & Nursing Care

Vancouver, British Columbia, Canada
November 11-12, 2019

38th Annual Conference on Advances in Cancer Research and Therapy

| Rafael Hoteles forum Alcala Bulgaria, 2 | 28802 Alcalá de Henares, Madrid, Spain
November 11-12 2019

3rd Cancer Diagnostics & Treatment Conference

Frankfurt, Germany
November 18-19, 2019

5th World Congress on Cancer and Diagnostics

Osaka, Japan
December 4-5, 2019

Asia Pacific Oncology and Cancer Conference

Tokyo, Japan
February 10-11, 2020

24th Global Annual Oncologists Meeting

Auckland, New Zealand
November 11-12, 2020

4th Global Summit on Cancer

| Tokyo, Japan
March 09-10, 2020

40th Euro Congress on Cancer Science & Therapy

Rome, Italy
March 30-31 | 2020

20th Global Cancer Summit

| Kyoto, Japan
April 13-14, 2020

World Congress on Women Oncology & Care

Tokyo , Japan
April 29-30, 2020

11th EURO BREAST CANCER SUMMIT

Prague, Czech Republic
June 11-12 | 2020

10th World Congress on Breast Cancer & Therapies

| Singapore
June 15-16, 2020

5th World Congress on Cancer and Diagnostics

Berlin, Germany
June 22-23, 2020

18th Asia Pacific
Oncologists Annual Meeting

Brisbane, Australia
July 09-10, 2020

5th International Conference on Preventive Oncology

Berlin, Germany

Cancer Epidemiology, screening, Diagnosis & Prognosis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in